Cargando…
Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer
[Image: see text] The repertoire of methods for the detection and chemotherapeutic treatment of prostate cancer (PCa) is currently limited. Prostate-specific membrane antigen (PSMA) is overexpressed in PCa tumors and can be exploited for both imaging and drug delivery. We developed and characterized...
Autores principales: | Rosenfeld, Lior, Sananes, Amiram, Zur, Yuval, Cohen, Shira, Dhara, Kalyan, Gelkop, Sigal, Ben Zeev, Efrat, Shahar, Anat, Lobel, Leslie, Akabayov, Barak, Arbely, Eyal, Papo, Niv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383930/ https://www.ncbi.nlm.nih.gov/pubmed/32442375 http://dx.doi.org/10.1021/acs.jmedchem.0c00418 |
Ejemplares similares
-
Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers
por: Sananes, Amiram, et al.
Publicado: (2023) -
Engineering Stem Cell Factor Ligands with Different c-Kit Agonistic Potencies
por: Tilayov, Tal, et al.
Publicado: (2020) -
A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and α(v)β(3) integrin for osteoporosis therapy
por: Zur, Yuval, et al.
Publicado: (2018) -
A KLK4 proteinase substrate capture approach to antagonize PAR1
por: Rabinovitch, Eitan, et al.
Publicado: (2021) -
Tuning the Properties of Protein-Based Polymers Using High-Performance Orthogonal Translation Systems for the Incorporation of Aromatic Non-Canonical Amino Acids
por: Gueta, Osher, et al.
Publicado: (2022)